-
Product Name
EMILIN1 antibody
- Documents
-
Description
EMILIN1 Rabbit Polyclonal antibody. Positive IHC detected in human ovary tumor. Positive WB detected in human kidney tissue, human brain tissue, human placenta tissue. Observed molecular weight by Western-blot: 120kd
-
Tested applications
ELISA, WB, IHC
-
Species reactivity
human; other species not tested.
-
Alternative names
EMILIN1 antibody; gp115 antibody; EMILIN antibody; DKFZp586M121 antibody; EMILIN 1 antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of EMILIN1 recombinant protein (Accession Number: BC007530). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:500-1:5000
IHC: 1:20-1:200
-
Validations
human kidney tissue were subjected to SDS PAGE followed by western blot with Catalog No:110239(EMILIN1 antibody) at dilution of 1:300
Immunohistochemical of paraffin-embedded human ovary tumor using Catalog No:110239(EMILIN1 antibody) at dilution of 1:100 (under 10x lens)
-
Background
EMILIN1, also named as EMILIN, EMILIN-1, gp115 and EMI, may be responsible for anchoring smooth muscle cells to elastic fibers, and may be involved not only in the formation of the elastic fiber, but also in the processes that regulate vessel assembly. It has cell adhesive capacity. EMILIN1 is a negative regulator of the transforming growth factor-beta (TGF-beta) signaling, which is involved in blood pressure (BP) homeostasis. ( PMID:20186130 ) EMILIN1 may play a key role in hypertensive vascular remodeling. TGFβ proteins are the main regulators of blood vessel development and maintenance, and EMILIN1 inhibits TGFβ signaling by binding specifically to the proTGFβ precursor and preventing its maturation by furin convertases in the extracellular space.(PMID:19922630 )
-
References
- Lee GY, Haverty PM, Li L. Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes. Cancer research. 74(11):3114-26. 2014.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"